AXGNAxogen, Inc.
38.63USD-0.41%Mkt Cap: 2.07B USDP/E: Last update: 2026-06-01

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a pro…

Indicators:|

Key Statistics

Company
Market Cap2.07B USD
Enterprise Value2.02B USD
Revenue (TTM)238.10M USD
Gross Profit167.35M USD
Net Income (TTM)-15.70M USD
Revenue/Share4.997 USD
Last Price38.63 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees622
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)54.21
PEG99.04
EV/EBITDA-945.43
EV/Revenue8.48
P/S8.82
P/B8.57
EPS (TTM)-0.64
EPS (Forward)0.73
52W Range
9.22080% of range45.83
52W High45.83 USD
52W Low9.220 USD
Profitability
Gross Margin74.31%
Oper. Margin-4.61%
EBITDA Margin-0.90%
Profit Margin-6.97%
ROE-12.19%
ROA-7.08%
Growth
Revenue Growth26.60%
Earnings Growth
Cash Flow & Leverage
Operating CF812.00K USD
CapEx (TTM)5.59M USD
FCF Margin7.68%
FCF Yield0.88%
Net Debt-80.96M USD
Net Debt/EBITDA37.92
Balance Sheet
Debt/Equity0.52
Current Ratio7.10
Quick Ratio4.99
Book Value/Sh4.606 USD
Cash/Share1.911 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateJan 27, 2010
Pay DateFeb 12, 2010
Splits
Last Split105:100
Split DateJul 11, 1994
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)50.78 USD
Target Range48.00 USD55.00 USD
# Analysts9
Ownership
Shares Out.53.18M
Float51.90M
Insiders2.10%
Institutions94.61%
Short Interest
Short Ratio2.7d
Short % Float6.97%
Short % Out.6.02%
Shares Short3.20M
Short (prev mo.)3.73M
Technical
SMA 5037.49 (+3.0%)
SMA 20028.40 (+36.0%)
Beta1.17
S&P 52W Chg27.94%
Avg Vol (30d)906.29K
Avg Vol (10d)827.80K
Technical Indicators
RSI (14)43.1
MACD0.5273
MACD Signal1.1056
MACD Hist.-0.5783
BB Upper44.29 USD
BB Middle41.63 USD
BB Lower38.97 USD
BB Width12.77%
ATR (14)1.797 USD
Vol Ratio (20d)0.35x